Archive · 18 Nov 2025
Major Stake Sales in Indian Tech and Pharma Companies
Some big investment companies are selling parts of their ownership in different Indian tech and pharma companies.
For Mphasis, the owners want to sell about 9.5% of the company's shares at a price a bit lower than the current price.
For Paytm, the owners want to sell about 2% of the company's shares at a price a little lower than the current price.
For Emcure Pharma, the owners might sell about 2% of the shares at a price about 7% lower than the current price.
These sales are happening through a process called block deals, which are large sales of shares all at once.
The sellers have promised not to sell more shares for 60 to 180 days.
Blackstone to sell 9.5% stake in Mphasis via block deal at a 4.4% discount
SAIF III Mauritius, SAIF Partners, and Elevation Capital to sell 2% stake in Paytm
Bain Capital to sell up to 2% of Emcure Pharma at a 7% discount
Block deals to raise up to ₹6,800 crore across three companies
60-180 day lock-up periods for sellers
- Who
- Blackstone (Mphasis), SAIF III Mauritius, SAIF Partners, Elevation Capital (Paytm), Bain Capital (Emcure Pharma)
- What
- Stake sales in Mphasis, Paytm, and Emcure Pharma
- When
- Tuesday's trading session
- Where
- Stock market
- Why
- To raise capital
Investors
Company Management
Stake Sale
Investors
To raise capital and benefit from recent financial performance
Company Management
Potential impact on company's future direction and valuation
- Mphasis Stake Sale
- 9.5% of Mphasis at ₹2,570 per share (4.4% discount)
- Paytm Stake Sale
- 2% of One 97 Communications Ltd at ₹1,281 per share (3.9% discount)
- Emcure Pharma Stake Sale
- Up to 2% of Emcure Pharma at ₹1,296.5 per share (7% discount)